Table 1 Characteristics of Study Patients (n = 137).

From: Metabolic radiogenomics in lung cancer: associations between FDG PET image features and oncogenic signaling pathway alterations

Characteristics

n (%)

Age, years (range)

62.7 ± 10.2 (29–82)

Male

101 (73.7%)

Smoking

Smoker

51 (37.2%)

Ex-smoker

46 (33.6%)

Never-smoker

39 (28.5%)

N/A

1 (00.7%)

ECOG performance status

0

17 (12.4%)

1

102 (74.5%)

2

8 (05.8%)

3−4

1 (00.7%)

N/A

9 (06.6%)

Pathology

ADC

61 (44.5%)

SQCC

31 (22.6%)

SCLC

45 (32.8%)

AJCC TNM staging 7th

T

1

19 (13.9%)

2

54 (39.4%)

3

34 (24.8%)

4

20 (14.6%)

N/A

10 (07.3%)

N

0

36 (26.3%)

1

17 (12.4%)

2

38 (27.7%)

3

39 (28.5%)

N/A

7 (05.1%)

M

0

75 (54.7%)

1a

12 (08.8%)

1b

27 (19.7%)

N/A

23 (16.8%)

  1. ECOG, Eastern Cooperative Oncology Group; N/A, not applicable; ADC, adenocarcinoma; SQCC, squamous cell carcinoma; SCLC, small cell lung cancer; AJCC, American Joint Committee on Cancer; T, tumor; N, node; M, metastasis.
Back to article page